MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Cogent Biosciences, Inc. (COGT)

Cogent Biosciences, Inc. (COGT)

|||

Balance Sheets Overview

Current Ratio
1357.29%
Quick Ratio
1357.29%
Cash Ratio
305.54%
Debt to Asset Ratio
36.21%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term marketable securities
    • Cash and cash equivalents
    • Operating lease, right-of-use as...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Convertible senior notes, net
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
181,172
241,208
312,012
125,297
Short-term marketable securities
611,128
625,170
588,753
265,593
Prepaid expenses and other current assets
12,520
11,425
9,590
6,354
Total current assets
804,820
877,803
910,355
397,244
Operating lease, right-of-use assets
22,596
17,549
18,078
18,591
Property and equipment, gross
-
-
14,136
-
Accumulated depreciation
-
-
8,679
-
Property and equipment, net
4,775
5,298
5,457
5,274
Restricted cash
416
416
416
336
Other assets
1,939
1,940
3,301
4,488
Total assets
834,546
903,006
937,607
425,933
Accounts payable
7,488
13,744
9,504
16,029
Accrued expenses and other current liabilities
50,319
42,854
52,902
44,511
Operating lease liabilities
1,489
1,383
1,547
1,706
Total current liabilities
59,296
57,981
63,953
62,246
Long-term debt, net
-
-
-
44,250
Convertible senior notes, net
223,457
223,173
222,895
-
Operating lease liabilities, net of current portion
19,315
14,097
14,355
14,603
Other liabilities
90
62
33
2,370
Total liabilities
302,158
295,313
301,236
123,469
Preferred stock, value-Series ANon Voting Convertible Preferred Stock
29,190
29,190
53,830
53,830
Preferred stock, value-Series BNon Voting Convertible Preferred Stock
35,563
35,563
35,563
54,085
Common stock, 0.001 par value 300,000,000 shares authorized 171,598,409 and 160,980,024 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
171
171
161
141
Additional paid-in capital
1,850,411
1,828,956
1,734,882
1,280,128
Accumulated other comprehensive income (loss)
-770
-415
355
208
Accumulated deficit
-1,382,177
-1,285,772
-1,188,420
-1,085,928
Total stockholders equity
532,388
607,693
636,371
302,464
Total liabilities and stockholders equity
834,546
903,006
937,607
425,933
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term marketablesecurities$611,128K (454.31%↑ Y/Y)Cash and cashequivalents$181,172K (41.99%↑ Y/Y)Prepaid expenses andother current assets$12,520K (74.86%↑ Y/Y)Total current assets$804,820K (228.49%↑ Y/Y)Operating lease,right-of-use assets$22,596K (18.32%↑ Y/Y)Property and equipment,net$4,775K (-18.38%↓ Y/Y)Other assets$1,939K (-60.12%↓ Y/Y)Restricted cash$416K Total assets$834,546K (203.67%↑ Y/Y)Total liabilities andstockholders equity$834,546K (203.67%↑ Y/Y)Total stockholdersequity$532,388K (243.40%↑ Y/Y)Total liabilities$302,158K (152.26%↑ Y/Y)Accumulated deficit-$1,382,177K (-37.53%↓ Y/Y)Accumulated othercomprehensive income (loss)-$770K (-6023.08%↓ Y/Y)Additional paid-in capital$1,850,411K (75.90%↑ Y/Y)Convertible senior notes,net$223,457K Total currentliabilities$59,296K (1.50%↑ Y/Y)Operating leaseliabilities, net of current...$19,315K (28.33%↑ Y/Y)Other liabilities$90K (-96.18%↓ Y/Y)Preferred stock,value-Series BNon Voting...$35,563K (-34.25%↓ Y/Y)Preferred stock,value-Series ANon Voting...$29,190K (-45.77%↓ Y/Y)Common stock, 0.001 parvalue 300,000,000...$171K (50.00%↑ Y/Y)Accrued expenses andother current...$50,319K (25.36%↑ Y/Y)Accounts payable$7,488K (-54.96%↓ Y/Y)Operating leaseliabilities$1,489K (-10.19%↓ Y/Y)